Davita Healthcare Partners Inc (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,250,737 | 956,978 | 781,643 | 1,211,762 | 994,677 |
| Depreciation Amortization | 723,860 | 745,443 | 732,602 | 680,615 | 630,435 |
| Income taxes - deferred | -57,840 | -39,354 | -75,669 | 60,483 | 240,848 |
| Accounts receivable | -29,766 | 172,361 | -148,394 | -138,140 | -21,087 |
| Accounts payable and accrued liabilities | 1,699 | 26,890 | 87,481 | -30,320 | 37,200 |
| Other Working Capital | -29,821 | 194,535 | 101 | -140,639 | -104,172 |
| Other Operating Activity | 163,169 | 2,178 | 186,806 | 287,115 | 201,127 |
| Operating Cash Flow | $2,022,038 | $2,059,031 | $1,564,570 | $1,930,876 | $1,979,028 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,745 | 63,258 | -58,487 | -5,957 | 246 |
| PPE Investments | -555,443 | -567,985 | -603,429 | -641,465 | -624,402 |
| Net Acquisitions | -246,068 | -26,394 | -57,308 | -187,050 | -182,013 |
| Purchase Of Investment | -5,205 | -276,202 | -31,885 | -13,924 | -22,341 |
| Purchase Sale Intangibles | 25,862 | 30,610 | 117,582 | 61,464 | N/A |
| Other Investing Activity | 32,542 | 35,523 | 120,762 | 63,663 | 3,139 |
| Investing Cash Flow | $-771,429 | $-771,800 | $-630,347 | $-784,733 | $-825,371 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 6,624,310 | 2,468,341 | 2,393,116 | 1,615,370 | 4,046,775 |
| Debt Repayment | -5,515,213 | -3,020,956 | -2,404,395 | -861,115 | -4,110,304 |
| Common Stock Issued | 20,453 | 16,900 | 18,577 | -60,001 | -975 |
| Common Stock Repurchased | -1,385,932 | -272,219 | -802,228 | -1,538,626 | -1,458,442 |
| Other Financing Activity | -560,555 | -362,561 | -326,198 | -238,594 | -323,831 |
| Financing Cash Flow | $-816,937 | $-1,170,495 | $-1,121,128 | $-1,082,966 | $-1,846,777 |
| Exchange Rate Effect | -18,481 | 8,909 | -29,066 | -10,007 | -13,808 |
| Beginning Cash Position | 464,634 | 338,989 | 554,960 | 501,790 | 1,208,718 |
| End Cash Position | 879,825 | 464,634 | 338,989 | 554,960 | 501,790 |
| Net Cash Flow | $415,191 | $125,645 | $-215,971 | $53,170 | $-706,928 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,022,038 | 2,059,031 | 1,564,570 | 1,930,876 | 1,979,028 |
| Capital Expenditure | -555,443 | -567,985 | -603,429 | -641,465 | -674,541 |
| Free Cash Flow | 1,466,595 | 1,491,046 | 961,141 | 1,289,411 | 1,304,487 |